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Abstract To systematically investigate putative causes of
non-coronary high-sensitive troponin elevations in patients
presenting to a tertiary care emergency department. In this
cross-sectional analysis, patients who received serial
measurements of high-sensitive troponin T between 1
August 2010 and 31 October 2012 at the Department of
Emergency Medicine were included. The following puta-
tive causes were considered to be associated with non-
acute coronary syndrome-related increases in high-sensi-
tive troponin T: acute pulmonary embolism, renal insuffi-
ciency, aortic dissection, heart failure, peri-/myocarditis,
strenuous exercise, rhabdomyolysis, cardiotoxic chemo-
therapy, high-frequency ablation therapy, defibrillator
shocks, cardiac infiltrative disorders (e.g., amyloidosis),
chest trauma, sepsis, shock, exacerbation of chronic
obstructive pulmonary disease, and diabetic ketoacidosis.
During the study period a total of 1,573 patients received
serial measurements of high-sensitive troponin T. Of these,
175 patients were found to have acute coronary syndrome
leaving 1,398 patients for inclusion in the study. In 222
(30 %) of patients, no putative cause described in the lit-
erature could be attributed to the elevation in high-sensitive
troponin T observed. The most commonly encountered
mechanism underlying the troponin T elevation was renal
insufficiency that was present in 286 patients (57 %), fol-
lowed by cerebral ischemia in 95 patients (19 %), trauma
in 75 patients (15 %) and heart failure in 41 patients (8 %).
Non-acute coronary syndrome-associated elevation of
high-sensitive troponin T levels is commonly observed in
the emergency department. Renal insufficiency and acute
cerebral events are the most common conditions associated
with high-sensitive troponin T elevation.
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Introduction
Troponins are a component of skeletal muscles as well
as the myocardium, and current assays are used to detect
the cardiac isoforms. Cardiac troponins are used as
biomarkers for detection of acute myocardial infarction
in the setting of chest pain, electrocardiogram (ECG)
abnormalities and cardiac wall abnormalities and their
use is recommended by current clinical guidelines [1].
Unlike former tests for cardiac troponins, the new high-
sensitivity assays are able to detect circulating troponins
in healthy patients without any underlying pathology
(high-sensitive troponin T \0.014 mcg/L). However,
non-coronary-related conditions were described to cause
increases in cardiac troponins which should be consid-
ered in the differential diagnosis in patients presenting
with troponin elevations [1]. Among the list of putative
causes of myocardial injury-related elevations of troponin
in patients are acute pulmonary embolism, renal insuffi-
ciency, peri-/myocarditis, heart failure or exacerbations
of chronic obstructive pulmonary disease [2]. A recent
observational study found that age, renal insufficiency
and arterial hypertension were risk factors for an ele-
vated troponin T level among patients presenting to the
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emergency department with a non-coronary putative
cause of troponin T elevation [3]. Another recent large
observational study from China confirmed the finding of
incidentally elevated serum troponin T levels in patients
with renal insufficiency [4]. However, despite the fre-
quent observation of non-coronary troponin T elevations,
the causes of elevations of the recently implemented
high-sensitive elevation have never been studied sys-
tematically in patients presenting to the emergency
department.
We aimed to study the prevalence of non-coronary high-
sensitive troponin T elevations in patients presenting to a
large, tertiary care emergency department and identify the
putative causative factors for the elevation. Additionally,
we tried to identify factors being associated with high-
sensitive troponin T elevation.
Methods
In this cross-sectional analysis, all patients age 16 years or
older who received serial measurements of high-sensitive
troponin T between 1 August 2010 (implementation of
high-sensitive troponin T measurement at our central lab-
oratory) and 31 October 2012 at the Department of
Emergency Medicine, Inselspital, University Hospital Bern
were included. We included patients with serial high-sen-
sitive troponin measurements (to rule out acute myocardial
infarction) only, since a definite myocardial infarction
exclusion is better performed on serial measurement of
serum troponins. High-sensitive troponin T was determined
at the Center for Laboratory Medicine using the Roche
Modular E170, an electrochemiluminescence immunoas-
say. A value of high-sensitive troponin T \0.014 mcg/L,
equaling the 99th percentile in a normal collective, is
considered normal according to our local reference ranges
of the Center for Laboratory Medicine. High-sensitive
troponin T levels ordered by the Department of Emergency
Medicine were considered for the analysis only. The
decision to order a measurement of high-sensitive troponin
T was at the discretion of the emergency physician.
Of all patients with measurement of serial high-sensitive
troponin T, the following data were obtained by the same
two persons (GL, CAP): age, sex, reason for emergency
department referral, previously known coronary arteries
disease, cardiovascular risk factors (diabetes mellitus,
dyslipidemia, arterial hypertension, smoking, obesity,
positive family history for cardiovascular events), presence
of ECG changes in the emergency department and final
diagnosis at the emergency department. Additionally, we
obtained data on length of hospitalization and in-hospital
mortality. The following laboratory data were gathered:
high-sensitive troponin T levels and serum creatinine. We
calculated estimated glomerular filtration rate according to
the modified diet in renal disease formula (MDRD) [5].
Patients with a diagnosis of acute coronary syndrome were
excluded from the study. The diagnosis of acute coronary
syndrome was made by the emergency physician in
accordance with the cardiologist in charge. The diagnosis
of acute coronary syndrome was made at the discretion of
the emergency physician by use of patient history, physical
examination, ECG and laboratory values (i.e., high-sensi-
tive value). Acute myocardial infarction was diagnosed in
line with the current guidelines of the European Society of
Cardiology [1, 6]. In case of suspected acute coronary
syndrome, cardiologists were informed, who then usually
hospitalize patients on their intermediate care ward for
monitoring and treatment before potential coronary
angiography.
Patients with elevated high-sensitive troponin levels in
whom presence of acute coronary syndrome was exclu-
ded by serial troponin measurements and serial ECGs
were screened for underlying conditions known to be
associated with an elevation in cardiac troponins. The
following putative causes were considered to be causa-
tive for a non-acute coronary syndrome-related increase
in high-sensitive troponin T: acute pulmonary embolism,
renal insufficiency, aortic dissection, heart failure, peri-/
myocarditis, strenuous exercise, rhabdomyolysis, cardio-
toxic chemotherapy, high-frequency ablation therapy,
defibrillator shocks, cardiac infiltrative disorders (e.g.,
amyloidosis), chest trauma, sepsis, shock, exacerbation of
chronic obstructive pulmonary disease and diabetic ke-
toacidosis [2, 4, 7–17]. Renal insufficiency was only
considered to be associated with high-sensitive troponin
T elevation when a CKD-EPI estimated GFR below
60 ml/min was present.
Statistical analysis
All data were collected prospectively and administered in
the research database of the Department of Emergency
Medicine. All data are presented as means and standard
deviation (SD) or medians and first and third quartiles, as
appropriate. Mann–Whitney U tests and t tests were per-
formed to compare medians and means as appropriate.
Statistical operations were performed by use of Statistica
Version 10.0, Statsoft Inc., Tulsa, OK. A p value of\0.05
was considered to be significant for all analyses.
Ethics statement
The study was conducted following the STROBE guide-
lines and approved by our local institutional review board,
the Ethics Commission of the Canton of Bern (www.kek-
bern.ch).
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Results
During the study period a total of 1,573 patients received
serial measurements of high-sensitive troponin T. Of these,
175 patients were found to have acute coronary syndrome
by clinical, electrocardiographic and laboratory assessment
by the emergency physician and the cardiologist in charge
leaving 1,398 patients for inclusion in the study. Of these
1,398 patients, 931 (67 %) were male and 467 (33 %) were
female. Median age at presentation was 67 years (54–79).
Median level of first high-sensitive troponin T was 0.014
mcg/L (0.004–0.029). 727 patients (52 %) had an initial
high-sensitive troponin T level exceeding the normal range
of \0.014 mcg/L. Median control values after 3–6 h were
0.015 mcg/L (0.004–0.032). Median change in percent
between first and second high-sensitive troponin T deter-
mination was 0 % (-5 to 14).
506 patients (70 %) had at least one of the putative
causes of troponin T elevation mentioned in ‘‘Methods’’. In
221 (30 %) of the patients, no cause described in the lit-
erature could be attributed to the elevation in high-sensitive
troponin T observed. The most commonly encountered
mechanism underlying the troponin T elevation was renal
insufficiency as present in 286 patients (57 %), followed by
cerebral ischemia in 95 patients (19 %), trauma in 75
patients (15 %) and heart failure in 41 patients (8 %). A
detailed overview of the various potential causes of ele-
vation of high-sensitive troponin T is given in Fig. 1.
High-sensitive troponin T levels according to the cause
of troponin elevation are given in Table 1. Patients with a
detectable putative cause of troponin elevation had a sig-
nificantly higher troponin level than patients without a
detectable cause (0.029 [0.02–0.054] vs. 0.026
[0.018–0.037], p \ 0.001). Patients with a detectable
putative cause of high-sensitive troponin T elevation were
significantly older than patients whose cause for troponin
Fig. 1 Overview on the
putative causes of high-sensitive
troponin T elevation in 506
patients admitted to the
emergency department.
Numbers given in percent
Table 1 Median and first and third quartile values of baseline high-
sensitive troponin T according to the putative cause of troponin
elevation
Putative cause of
troponin
elevation
N Percent Median
baseline
troponin
25th
percentile
75th
percentile
Renal
insufficiency
286 57 0.0325 0,021 0.063
Cerebral
ischemia
95 19 0.026 0.019 0.06
Intracranial
hemorrhage
5 1 0.034 0.02 0.04
Trauma 75 15 0.026 0.019 0.046
Hemorrhagic
shock
2 0.4 0.944 0.038 1.85
Seizure 27 5 0.027 0.018 0.032
Heart failure 41 8 0.04 0.024 0.056
Tachyarrhythmia 35 7 0.026 0.018 0.043
COPD
Exacerbation
9 2 0.039 0.03 0.05
Hypertensive
crisis
22 4 0.0245 0.018 0.063
Acute
pulmonary
embolism
9 2 0.045 0.022 0.07
Sepsis 10 2 0.047 0.024 0.09
Head trauma 4 1 0.026 0.024 0.028
Rhabdomyolysis 4 1 0.025 0.018 0.035
Peri-/
myocarditis
6 1 0.125 0.016 0.373
Diabetic
ketoacidosis
3 0.7 0.0725 0.039 0.106
Defibrillator
shock
2 0.4 0.0245 0.023 0.026
Aortic dissection 1 0.2 0.024 0.024 0.024
Cardiac arrest 1 0.2 0.097 0.097 0.097
Cocaine abuse 1 0.2 0.074 0.074 0.074
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elevation remained unknown (74 ± 15 vs. 68 ± 15 years,
p \ 0.0001). Table 2 gives an overview on the cardiac risk
factors in patients with and without high-sensitive troponin
elevation.
Discussion
In the present study, we found that more than 50 % of
patients receiving serial high-sensitive troponin T measure-
ment in the emergency department were found to have non-
coronary elevation of the biomarker, i.e., myocardial injury
caused by a non-acute coronary syndrome cause. 3–6 h
control values remained stable in most patients. Renal
insufficiency (eGFR \60 ml/min) was the most common
putative cause attributable to the elevation in high-sensitive
troponin T as present in 57 % of patients. Cerebral ischemia
(19 %), trauma (15 %) and heart failure (8 %) were also
commonly observed causes of non-coronary high-sensitive
troponin elevation. We found that patients with hemorrhagic
shock followed by patients with a diagnosis of peri-/myo-
carditis had the highest high-sensitive troponin levels.
Recent studies have well described the association
between renal insufficiency or age and an elevated high-
sensitive troponin T level [3, 4]. However, current guide-
lines do still lack a clear recommendation on how to handle
elevated high-sensitive troponin levels in asymptomatic
patients without a concrete suspicion of cardiac ischemia
[1]. This is probably due to the lack of data on the absolute
values of high-sensitive troponin T levels in these patients,
making a statement on what is to be considered normal in
the specific patient difficult. Additionally, the mechanisms
underlying the troponin elevations in patients of older age
or with renal insufficiency have not been clarified so far.
The elevation of high-sensitive troponin T in other factors
such as acute pulmonary embolism or acute heart failure
could potentially be explained by an acutely stressed
myocardium by the acute event. In our study, we were able
to identify factors associated with an elevated high-sensi-
tive troponin T on admission to the emergency department:
presence of diabetes mellitus and use of platelet inhibitors
or Coumadin were associated with an elevated high-sen-
sitive troponin T. This is probably due to a higher preva-
lence of coronary artery disease in these patients
predisposing them to myocardial injury in case of an acute
event (e.g., sepsis, trauma) according to myocardial stress.
However, the lower prevalence of high-sensitive troponin
T elevations in smokers remains unclear and might be
incidental. It should also be noted that unlike older assays,
the new high-sensitivity assays for cardiac troponins are
able to detect ‘‘normal’’ concentrations of cardiac troponins
that are not associated with an underlying pathology.
Limitations
Our study has some limiting factors which should be of
note: the exact history is sometimes difficult to obtain in
the emergency department setting. Thus, we cannot
exclude that some patients with a history of trauma had
unrecognized chest trauma. We can also not exclude that in
patients who were unresponsive, all data on the history of
coronary artery disease and current medication were
obtained completely and accurately. Additionally, it should
be said that we were not able to detect a known potential
cause of elevated high-sensitive troponin levels in 30 % of
patients.
Conclusions
In conclusion, we showed that non-coronary high-sensitive
troponin T elevations are common in patients presenting to
the emergency department who receive measurements of
the biomarker. Renal insufficiency and acute cerebral
events were the most common putative causes of an ele-
vated high-sensitive troponin T. Prospective studies should
be performed to attempt find a reference range, adjusted for
age and renal function, to avoid unnecessary diagnostic
procedures in these patients.
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